Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Morinaga Milk claims ACE-inhibitory tripeptide with in vivo antihypertensive activity

July 3, 2003

Phase III ARISE trial of AGI-1067 opens enrollment

July 2, 2003

FDA approves Pravigard PAC

July 1, 2003

ETC-216 produces regression of atherosclerosis

July 1, 2003

MLN-2201 enters phase I testing

June 30, 2003

Enrollment completed in ONTARGET trial of Micardis

June 27, 2003

Novel aquaretic and antivasopressor agent targeting both V1a and V2 receptors

June 25, 2003

ZP-123 prevents ischemia-induced ventricular tachycardia via effects on gap junctions

June 25, 2003

New LXR ligands and their use described by Merck researchers

June 25, 2003

Encysive receives SPA from the FDA for sitaxsentan

June 20, 2003

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...